CBI team arrests Joint Drug Controller for accepting bribe from a private company director

New Delhi: The Central Bureau of Investigation has apprehended a Joint Drug Controller (JDC), posted at CDSCO (Central Drugs Standard Control Organisation()Headquarters, New Delhi and a director of private company based at Delhi in an alleged bribery of Rs. four lakh.

A case was registered against a Joint Drug Controller (India) (JDC), CDSCO Headquarters, New Delhi and others including Directors, Associate Vice President & Head-National Regulatory Affairs (NRA) of separate private companies, two based at New Delhi and another at Bengaluru; Assistant Drug Inspector (ADI), CDSCO, New Delhi and other unknown officials of CDSCO. It was alleged in FIR that the accused was trying to exert undue influence on officers of CDSCO under Directorate General of Health Services. It is alleged that influence was for waiving the Phase III trial of “Insulin Aspart Injection” and the accused agreed to pay bribe amount of Rs.9,00,000/- to JDC for favorably processing the said three files related to private company based at Bangalore and also for favourably recommending the file of “Insulin Aspart injection” to the Subject Expert Committee (SEC) meeting.

In fact, CBI had laid a trap wherein the JDC of CDSCO was caught while accepting bribe of Rs. 4,00,000/- from the Director of Delhi based private company and meanwhile, the said Director of Delhi based private company was also caught with Drug Controller.

Related Posts

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

UP expands food, drug testing capacity across all 18 divisions

UP expands food, drug testing capacity across all 18 divisions

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi